The Covid-19 pandemic has made the issue of healthcare access more urgent than ever. Yet, at a time of deep divisions in Washington, chances for major reform are slim.
The Biden administration doesn’t need an ambitious package of reforms to make health care more affordable. Federal officials could instead focus on fixing dysfunctional programs already on the books.
A drug discount program known as 340B should be high on their list. Its original goal was to make brand-name drugs more affordable for uninsured and low-income populations. Instead, pharmacies and hospitals have abused 340B discount...
Reader Comments(0)